Economy

What Does Insider Trading Tell Us About PAREXEL International Corporation (PRXL)?

PAREXEL International Corporation (NASDAQ:PRXL) reported its EPS in the last quarter as $1.02/Share beating the analyst estimate of $0.93/Share by a difference of $0.09. Meadow Creek Investment Management LLC now owns 1,980 shares of the medical research company's stock worth $125,000 after acquiring an additional 132 shares in the last quarter. The institutional investor owned 370,138 shares of the medical research company's stock after acquiring an additional 111,691 shares during the quarter.

According to PAREXEL International Corporation's latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 0%.

A number of other institutional investors also recently modified their holdings of the stock. Amalgamated Bank increased its stake in PAREXEL International Corporation by 0.6% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in PAREXEL International Corporation by 10.0% in the second quarter. Texas Permanent School Fund increased its stake in PAREXEL International Corporation by 0.5% during the 2nd quarter. Finally, Cowen Inc. acquired a new stake in shares of PAREXEL International Corporation in the 2nd quarter worth about $7,886,000. The correct version of this piece can be viewed at https://stocknewstimes.com/2017/10/02/halcyon-management-partners-lp-purchases-new-position-in-parexel-international-corporation-prxl.html.

PRXL has been the subject of several analyst reports. Zacks Investment Research upgraded PAREXEL International Corporation from a "hold" rating to a "buy" rating and set a $98.00 price objective for the company in a report on Thursday, August 31st. BidaskClub downgraded shares of PAREXEL International Corporation from a "strong-buy" rating to a "buy" rating in a report on Friday, July 28th.

PAREXEL International Corporation (NASDAQ:PRXL) touched its 1-Year High price of $88.10 on 09/29/17 and its 1-Year Low price of $51.16 on 11/11/16.

The price target set for the stock is $86.71 and this sets up an interesting set of potential movement for the stock, according to data from Finviz's Research. Raymond James Financial, Inc. upgraded PAREXEL International Corporation from an "underperform" rating to a "mkt perform" rating in a research note on Tuesday, June 20th.

Analysts have given a mean recommendation of 3.00 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range).

The average Wall Street analyst rating for PAREXEL International Corporation is Hold, according to the average of 14 analyst scores. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of USA & global copyright & trademark legislation. The company's stock had a trading volume of 7,021,106 shares.

PAREXEL International Corporation (NASDAQ:PRXL) closed its last session at $88.08. The stock has a 50 day moving average of $87.74 and a 200 day moving average of $78.14. The co's performance for 6 months was isolated positively of 3.72%, 1-year performance stands at 52.45% and year to date showing moved up performance of 2.13%. The firm has a market capitalization of $4.50 billion, a P/E ratio of 42.76 and a beta of 0.77.

PAREXEL International Corporation (NASDAQ:PRXL) last announced its earnings results on Monday, August 28th. It has a return on equity (ROE) of 17.70%.

Celldex Therapeutics, Inc. (CLDX) revenue scored -31.37% growth from the previous quarter, coming up with $1.05 million.

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. Whereas, in last 21 trading days (one month) was climbed 8.17% and moved down in last 63 trading days (quarter) of -0.37%. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services.



Like this

loading...
loading...

Latest


02 October 2017
Accused Chelsea bomber booted from courtroom over outburst
He also faces charges in New Jersey for planting bombs there, and for a shootout with police when he was captured. Rahimi, 29, faces eight counts related to allegedly planting two bombs in Chelsea on September 17, 2016.

02 October 2017
Catholic MP linked to abortion pill firm
Rees-Mogg opposes abortion in all circumstances including rape as he believes that "life begins at the point of conception". The MP ran into controversy over the summer after his unlikely hopes of becoming Tory leader burst into public view.

02 October 2017
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) Moving Today - Up by 22.59%
At the end of June reporting period, 12 institutional holders increased their position in Catabasis Pharmaceuticals, Inc. The most optimistic analyst sees the stock reaching $9 while the most conventional has $1.5 target price. (NASDAQ:CATB).

02 October 2017
Nissan Leaf Nismo concept heads to Tokyo
The second edition of the electrified NV200 van will provide customers with an extra 62 miles in range, offering 174 miles on a single charge.

02 October 2017
At Least 11 People Killed In Damascus Bomb Attack
The pro-Damascus al-Mayadeen TV channel said four militants carried out the attack, killing more than 10 people. The 11 dead included police officers and civilians, the SOHR said, adding that the attack also caused injuries.

02 October 2017
Marilyn Manson Injured in Stage Accident, Postpones Tour
Manson was taken from the venue on a stretcher but is expected to resume his tour on October 15 in Grand Prairie, Texas. Manson's reps said the most significant injury affected his leg, but that the hard rocker would be "fine".

02 October 2017
HTC Vive Fallout 4 VR bundle available now
It's full-priced - £40 - but not due until 12th December so HTC will give you a redemption code for it. If you've been on the fence about buying a VR headset, as in, you're still not sure which one to buy.

02 October 2017
Dalit man beaten to death for attending Garba in Gujarat
The accused made casteist remarks and asked some men to come to the spot, said an officer at the Bhadran police station. Thereafter, the Patel men allegedly beat up the Dalits, banging Solanki's head against a wall.

02 October 2017
ISM US Manufacturing PMI Accelerates in September
Anything above 50 signals that manufacturers are growing, and the ISM survey shows they've been on a 13-month winning streak. Workers assemble built-in appliances at the Whirlpool manufacturing plant in Cleveland, Tennessee August 21, 2013.

02 October 2017
"Instagram King" Dan Bilzerian Films Himself Fleeing From Las Vegas Shooting
One suspect is "down", Sergeant Jeff Clark confirmed, and police say they do not believe there are any other gunmen. The shooting took place at the Route 91 Harvest country music festival at the Mandalay Bay casino-hotel.